Reactions Weekly

, Volume 1636, Issue 1, pp 58–58 | Cite as

Bevacizumab

Development of bevacizumab resistance in colorectal cancer: case report
Case report
  • 24 Downloads

Reference

  1. Kim S, et al. Complete Response to Aflibercept-FOLFIRI in One Patient With Colorectal Cancer Refractory to Bevacizumab-FOLFOX: A Possible Autocrine Vascular Endothelial Growth Factor Receptor 2-Related Mechanism. Clinical Colorectal Cancer 15: e229-e234, No. 4, 09 Aug 2016. Available from: URL: http://doi.org/10.1016/j.clcc.2016.07.015 - France

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations